Show channels:
All channels
Bladder cancer
Brain and spinal
Breast cancer
Cervical
Colon & rectal
Dermatological
General Information
Gynecological
Head and Neck
Kidney/adrenal
Liver
Lung
Lymphoma
Multiple Myeloma
Myelodysplastic syndromes
Myeloproliferative disorders
Pancreas
Pediatric
Prostate
Sarcoma
Stomach
Testicular
Thyroid
Upper aerodigestive
Found 16137 articles
Atezolizumab versus pembrolizumab in the treatment of advanced triple-negative breast cancer: a Bayesian network meta-analysis of ITT and PD-L1 positive populations
P + CT demonstrated superior long-term survival stability in ITT population.
»
05/29/26
Real-world data for a CDK4/6 inhibitor, palbociclib, as 1st- or 2nd-line therapy in HR+/HER2– metastatic breast cancer: a multicenter prospective cohort study
Neutropenia grade >3 occurred in 70% of patients.
»
05/29/26
Multi-omic profiles of neuroendocrine neoplasms of the pancreas: an integrated landscape
Advent of multiple omics-based methodologies significantly enhanced our understanding.
»
05/29/26
High-dose stereotactic radiotherapy boost in the radical treatment of head and neck tumors
Risk of late toxicity increased after exceeding biological effective dose of 143.33 Gy.
»
05/29/26
Acetyltransferase NAT10 promotes aggressiveness of colorectal cancer cells via ac4C acetylation of SERPINA1 mRNA
Down-regulation of NAT10 inhibited cell proliferation and invasion.
»
05/30/26
HyperSightTM-CBCT based monitoring of sarcopenia during definitive radiotherapy of prostate cancer: a longitudinal feasibility study
HyperSight™ CBCT enables quantitative skeletal-muscle assessment during prostate radiotherapy.
»
05/29/26
Modeling distress in cancer patients using a fuzzy logic approach based on expert consensus
Self-reinforcing "vicious cycle" of distress driven by Negative Psychological Factors.
»
05/30/26
In silico analysis of driver genes in squamous cell carcinoma of the cervix: insights into their biological functions, prognosis, immune infiltration, and therapy
Analysis revealed 9,749,109 mutations across 44 driver genes.
»
06/01/26
Tumor immune microenvironment and epithelial–mesenchymal transition in recurrence of low-grade stage IA endometrial endometrioid carcinoma
Tumor cell expression of CXCL12 significantly higher in recurrence group.
»
06/02/26
MiR-494-5p suppresses colorectal cancer metastasis by multi-level targeting of KAT2B, a novel mechanism disrupting KAT2B enhancer-promoter looping, and inhibiting c-JUN-driven pro-metastatic properties
c-JUN overexpression rescues metastatic phenotype suppressed by miR-494-5p.
»
06/02/26
< Prev
Next >